Medpace Holdings (MEDP) Fundamental Analysis: Revenue, Earnings & Valuation

9.88 / 10

Outperform

Fundamentals rate Outperform with a 9.9/10 score. Key strengths include PB‑ROE, Profit‑MV, Net‑income‑Revenue and Cash‑MV, while inventory turnover days and a high cost‑of‑sales ratio are drawbacks. Overall, fundamentals appear very promising.

Analysis Checks(7/10)

Profit-MV

Value0.31

Score2/3

Weight5.69%

1M Return0.17%

Net income-Revenue

Value0.45

Score3/3

Weight178.94%

1M Return4.11%

PB-ROE

Value7.54

Score2/3

Weight51.51%

1M Return1.39%

Current assets turnover ratio

Value2.51

Score3/3

Weight73.47%

1M Return2.34%

Cash-UP

Value-0.37

Score2/3

Weight-56.20%

1M Return-1.72%

Total assets turnover ratio

Value1.24

Score2/3

Weight49.36%

1M Return1.43%

Cost of sales ratio (%)

Value69.94

Score0/3

Weight-188.23%

1M Return-7.50%

Asset-MV

Value-0.55

Score1/3

Weight-29.87%

1M Return-0.83%

Inventory turnover days

Value210.83

Score1/3

Weight-80.22%

1M Return-2.65%

Cash-MV

Value-0.63

Score3/3

Weight95.55%

1M Return2.49%

Is MEDP fundamentally strong?

MEDP scores 9.88/10 on fundamentals and holds a Discounted valuation at present. Backed by its 70.23% ROE, 17.83% net margin, 29.37 P/E ratio, 28.86 P/B ratio, and 19.75% earnings growth, these metrics solidify its Outperform investment rating.